Heron Therapeutics, Inc. /De/

LOS ANGELES CAPITAL MANAGEMENT LLC HRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

248,567

Value ($000)

283

Weight

0.0%

2020 Q1 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	283	0.0%	248,567	12/31/2025
2025 Q3	10/20/2025	310	0.0%	246,413	9/30/2025
2025 Q2	8/7/2025	551	0.0%	266,128	6/30/2025
2025 Q1	5/5/2025	149	0.0%	67,803	3/31/2025
2024 Q4	2/4/2025	104	0.0%	67,653	12/31/2024
2024 Q3	11/4/2024	439	0.0%	220,834	9/30/2024
2024 Q2	8/5/2024	836	0.0%	238,899	6/30/2024
2024 Q1	4/5/2024	1,366	0.0%	493,264	3/31/2024
2023 Q4	2/6/2024	874	0.0%	514,377	12/31/2023
2023 Q3	11/6/2023	353	0.0%	343,127	9/30/2023
2023 Q2	8/3/2023	394	0.0%	339,474	6/30/2023
2023 Q1	5/4/2023	1,066	0.0%	705,677	3/31/2023
2022 Q4	2/6/2023	419	0.0%	167,653	12/31/2022
2022 Q3	11/2/2022	730	0.0%	173,053	9/30/2022
2021 Q1	5/5/2021	258	0.0%	15,940	3/31/2021
2020 Q4	3/10/2021	543	0.0%	25,650	12/31/2020
2020 Q3	11/2/2020	381	0.0%	25,700	9/30/2020
2020 Q2	8/5/2020	360	0.0%	24,470	6/30/2020
2020 Q1	5/4/2020	178	0.0%	15,194	3/31/2020